{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:55:10Z","timestamp":1788900910394,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.metabol.2015.03.003","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T01:19:08Z","timestamp":1426295948000},"page":"698-705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Glycated albumin as a diagnostic tool for diabetes in a general Japanese population"],"prefix":"10.1016","volume":"64","author":[{"given":"Hiroaki","family":"Ikezaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Furusyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Ura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hiramine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujiko","family":"Mitsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Kohzuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst J.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2015.03.003_bb0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2015.03.003_bb0010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)12131-1","article-title":"Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe","volume":"354","author":"The DECODE study group","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2015.03.003_bb0015","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.22.6.920","article-title":"Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study","volume":"22","author":"Tominaga","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.03.003_bb0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.03.003_bb0025","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2015.03.003_bb0030","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.metabol.2011.06.016","article-title":"The quest for the perfect biomarker of long-term glycemia: new studies, new trials and tributions","volume":"60","author":"Foo","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.03.003_bb0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.diabres.2011.03.012","article-title":"Report of a World Health Organization Consultation: use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus","volume":"93","author":"World Health Organization (WHO)","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2015.03.003_bb0040","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2337\/dc09-0836","article-title":"Association between iron deficiency and A1c levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006","volume":"33","author":"Kim","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.03.003_bb0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1753-0407.2010.00100.x","article-title":"Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US","volume":"3","author":"Ford","year":"2011","journal-title":"J Diabetes"},{"key":"10.1016\/j.metabol.2015.03.003_bb0050","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2337\/diacare.18.4.440","article-title":"Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level","volume":"18","author":"Tahara","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.03.003_bb0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1507\/endocrj.K06-103","article-title":"Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control","volume":"54","author":"Takahashi","year":"2007","journal-title":"Endocr J"},{"key":"10.1016\/j.metabol.2015.03.003_bb0060","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.metabol.2011.12.007","article-title":"The lack of long-range negative correlations in glucose dynamics is associated with worse glucose control in patients with diabetes mellitus","volume":"61","author":"Ogata","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.03.003_bb0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1507\/endocrj.K09E-234","article-title":"Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM)","volume":"57","author":"Suwa","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.metabol.2015.03.003_bb0070","first-page":"5509","article-title":"Glycated albumin and diabetes mellitus","volume":"2013","author":"Furusyo","year":"1830","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2015.03.003_bb0075","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopha.2008.04.002","article-title":"Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test","volume":"63","author":"Nagayama","year":"2009","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.metabol.2015.03.003_bb0080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.metabol.2009.08.008","article-title":"Association of glycated albumin, but not glycated hemoglobin, with calcaneus quantitative ultrasound in male hemodialysis patients with type 2 diabetes mellitus","volume":"59","author":"Yamada","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.03.003_bb0085","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1053\/meta.2002.33359","article-title":"Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db\/db mice","volume":"51","author":"Cohen","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2015.03.003_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03256353","article-title":"Lucica GA-L glycated albumin assay kit: a new diagnostic test for diabetes mellitus","volume":"14","author":"Kohzuma","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.metabol.2015.03.003_bb0095","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1007\/s00125-011-2310-6","article-title":"Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS)","volume":"54","author":"Furusyo","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2015.03.003_bb0100","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.ijcard.2012.05.045","article-title":"Plasma glycated albumin level and atherosclerosis: Results from the Kyushu and Okinawa Population Study (KOPS)","volume":"167","author":"Furusyo","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.metabol.2015.03.003_bb0105","article-title":"Associations between glycated albumin or hemoglobin A1c and the presence of coronary artery disease","author":"Norimatsu","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.metabol.2015.03.003_bb0110","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1253\/circj.71.1067","article-title":"Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetes patients","volume":"71","author":"Pu","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.metabol.2015.03.003_bb0115","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/dc10-1945","article-title":"Nontraditional markers of glycemia: associations with microvascular conditions","volume":"34","author":"Selvin","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.03.003_bb0120","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.metabol.2015.03.003_bb0125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2015.03.003_bb0130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/clinchem\/39.4.663","article-title":"Enzyme immunoassay: a new technique for estimating hemoglobin A1c","volume":"39","author":"John","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2015.03.003_bb0135","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1515\/CCLM.2007.158","volume":"45","author":"Goodall","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.metabol.2015.03.003_bb0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"Delong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.metabol.2015.03.003_bb0145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1373\/clinchem.2010.150250","article-title":"Determining stability of stored samples retrospectively: the validation of glycated albumin","volume":"57","author":"Nathan","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2015.03.003_bb0150","first-page":"3532","article-title":"New insights into deleterious impacts of in vivo glycation on albumin antioxidant activities","volume":"2013","author":"Baraka-Vidot","year":"1830","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2015.03.003_bb0155","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1172\/JCI117926","article-title":"Prevention of diabetic nephropathy in db\/db mice with glycated albumin antagonists. A novel treatment strategy","volume":"95","author":"Cohen","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2015.03.003_bb0160","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1006\/bbrc.1995.1219","article-title":"Evidence for a ligand receptor system mediating the biologic effects of glycated albumin in glomerular mesangial cells","volume":"207","author":"Wu","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2015.03.003_bb0165","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/dc12-0787","article-title":"Alternative markers of hyperglycemia and risk of diabetes","volume":"35","author":"Juraschek","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.03.003_bb0170","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00125-003-1158-9","article-title":"Age, body mass index and type 2 diabetes\u2014associations modified by ethnicity","volume":"46","author":"The DECODE-DECODA Study Group on behalf of the European Diabetes Epidemiology Group","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2015.03.003_bb0175","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.2337\/diab.41.12.1540","article-title":"Pathogenic factors responsible for glucose intolerance in patients with NIDDM","volume":"41","author":"Taniguchi","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2015.03.003_bb0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.7326\/0003-4819-154-5-201103010-00004","article-title":"Racial differences in glycemic markers: a cross-sectional analysis of community-based data","volume":"154","author":"Selvin","year":"2011","journal-title":"Ann Intern Med"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515000761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515000761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:05:41Z","timestamp":1758427541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049515000761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0026049515000761"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.03.003","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycated albumin as a diagnostic tool for diabetes in a general Japanese population","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}